Cough Hypersensitivity Syndrome Global Market Report 2024

Cough Hypersensitivity Syndrome Global Market Report 2024 – By Drug Class (Inhales Corticosteroids, Antitussive Agents, Short-acting Beta-2 Agonists, Anticholinergics, Proton Pump Inhibitors, Antihistamines, Other Drugs), By Route of Administration (Oral, Inhalation, Other Route Of Administration), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Cough Hypersensitivity Syndrome Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cough Hypersensitivity Syndrome Market Definition And Segments

Cough hypersensitivity syndrome (CHS) is a medical condition characterized by an exaggerated and abnormal response of the cough reflex to various stimuli, often leading to persistent and chronic coughing. It is commonly associated with conditions such as asthma, gastroesophageal reflux disease (GERD) and upper airway disorders.

The main drug types of cough hypersensitivity syndrome are inhaled corticosteroids, antitussive agents, short-acting beta-2 agonists, anticholinergics, proton pump inhibitors, antihistamines and others. Inhaled corticosteroids (ICS) refer to a class of medications used in the treatment of various respiratory conditions. The various route of administration includes oral, inhalation and others, used by various end-users such as hospitals, specialty clinics, homecare and others.

The cough hypersensitivity syndrome market covered in this report is segmented –

1) By Drug Class: Inhales Corticosteroids, Antitussive Agents, Short-acting Beta-2 Agonists, Anticholinergics, Proton Pump Inhibitors, Antihistamines, Other Drugs

2) By Route of Administration: Oral, Inhalation, Other Route Of Administration

3) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

The cough hypersensitivity syndrome market size has grown strongly in recent years. It will grow from $9.71 billion in 2023 to $10.36 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased awareness, telemedicine and remote monitoring, public health initiatives, research funding.

The cough hypersensitivity syndrome market size is expected to see strong growth in the next few years. It will grow to $13.51 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to global health access, patient advocacy and support, quality of life improvements. Major trends in the forecast period include improved diagnosis and screening tools, personalized treatment approaches, new medications.

Growing Prevalence Of Chronic Respiratory Diseases Boosts The Cough Hypersensitivity Syndrome Market

The rising prevalence of chronic respiratory diseases is expected to propel the growth of the cough hypersensitivity syndrome market going forward. Chronic respiratory diseases (CRDs) refer to a group of long-term diseases that affect the airways and lungs, leading to persistent breathing difficulties and reduced lung function over time. Cough hypersensitivity syndrome treatment reduces discomfort, enhances respiratory health, thereby improving the quality of life for patients suffering from chronic respiratory diseases such as asthma. For instance, in June 2023, according to the Australian Institute of Health and Welfare, an Australia-based national agency, almost one-third (30%) of the Australian population, that is, 7.5 million people, are suffering from chronic respiratory diseases. Additionally, in June 2023, according to the Centers for Disease Control and Prevention, a US-based public health agency, there were 142,342 deaths from chronic lower respiratory diseases in 2021. Therefore, the rising prevalence of chronic respiratory diseases drives the cough hypersensitivity syndrome market.

Rising Cigarette Smokers Boost Cough Hypersensitivity Syndrome Market Growth

The growing population of cigarette smokers is expected to propel the growth of the cough hypersensitivity syndrome market going forward. Cigarette smokers are individuals who regularly use tobacco by smoking cigarettes. This involves inhaling the smoke produced by burning tobacco leaves contained in a cylindrical paper-wrapped cigarette. Cigarette smoking causes cough hypersensitivity syndrome by irritating airways, promoting inflammation, and damaging lung tissues. For instance, in July 2022, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 5.8% compared to June 2021. Also, the total number of cigarettes sold rose by 1.3%, reaching 1.4 billion in June 2022. Furthermore, In May 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, an estimated 28.3 million U.S. adults smoke cigarettes, and about 3.08 million U.S. middle and high school students use at least one tobacco product. Every day, about 1,600 U.S. youth younger than 18 smoke their first cigarette. Therefore, the growing population of cigarette smokers is expected to propel the growth of the cough hypersensitivity syndrome market.

Major players in the cough hypersensitivity syndrome market are Pfizer Inc., Johnson and Johnson Ltd., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck and Co Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Wyeth Pharmaceuticals Inc., AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Mylan N.V., Lupin Limited, Cadila Pharmaceuticals, Almirall S.A., Akorn Operating Company LLC, Kudco Ireland Ltd., Prestige Consumer Healthcare Inc., GMP Laboratories of America Inc., The Betty Mills Company, Acura Pharmaceuticals Inc.

Drug Abuse Adversely Affects The Cough Hypersensitivity Syndrome

Drug abuse is expected to hamper the growth of the cough hypersensitivity syndrome market going forward. The use of these drugs can lead to dependence, abuse, or central side effects. Morphine and diamorphine are very addictive but are useful in treating severe distressing coughs in patients with terminal illnesses such as cough hypersensitivity syndrome. For instance, in June 2022, according to Springer Nature Limited, a Germany-based academic publishing company, the use of antitussive agents for cough hypersensitivity syndrome increased, and some of these agents, such as codeine and hydrocodone, are opioids that can cause addiction and substance use disorder. Therefore, drug abuse will negatively impact the growth of the cough hypersensitivity syndrome market.

Integration Of Ai-Powered Algorithms Drives Advancements In The Cough Hypersensitivity Syndrome Market

Major companies operating in the cough hypersensitivity syndrome market are adopting AI-powered algorithms to sustain their position in the market. AI-powered algorithms refer to computational processes and procedures that utilize artificial intelligence (AI) techniques to perform tasks or solve problems. For instance, in April 2021, NuvoAir, a US-based digital healthcare company, launched NuvoAir Cough, a mobile app for detecting cough hypersensitivity syndrome. This is a smartphone app that tracks coughs in domestic settings and is accessible for the iOS operating system. It detects a single cough or burst of coughs using the smartphone's microphone and an artificial intelligence (AI)-powered algorithm. The AI algorithm separates coughs from other sounds using the recorded sound and provides the results back to the user and their clinical physician.

Glaxosmithkline's Acquisition Of Bellus Health Boosts Respiratory Medication Portfolio

In June 2023, GlaxoSmithKline PLC, a UK-based pharmaceutical and biotechnology company that manufactures drugs for cough hypersensitivity syndrome, acquired Bellus Health Inc. for $2.0 billion. With this acquisition, GSK aims to strengthen its portfolio of respiratory medications, research and development (R&D), production and commercialization capabilities. Bellus Health Inc. is a Canada-based biotech company that develops drugs for cough hypersensitivity syndrome.

North America was the largest region in the cough hypersensitivity syndrome market in 2023. The regions covered in cough hypersensitivity syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cough hypersensitivity syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cough hypersensitivity syndrome market consists of sales of cough suppressants, steam inhalers and humidifiers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cough hypersensitivity syndrome market research report is one of a series of new reports from The Business Research Company that provides cough hypersensitivity syndrome market statistics, including cough hypersensitivity syndrome industry global market size, regional shares, competitors with a cough hypersensitivity syndrome market share, detailed cough hypersensitivity syndrome market segments, market trends and opportunities and any further data you may need to thrive in the cough hypersensitivity syndrome industry. This cough hypersensitivity syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cough Hypersensitivity Syndrome Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $10.36 billion
Revenue Forecast In 2033 $13.51 billion
Growth Rate CAGR of 6.9% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drug Class: Inhales Corticosteroids, Antitussive Agents, Short-acting Beta-2 Agonists, Anticholinergics, Proton Pump Inhibitors, Antihistamines, Other Drugs
2) By Route of Administration: Oral, Inhalation, Other Route Of Administration
3) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson and Johnson Ltd.; F. Hoffmann-La Roche AG; Bayer AG; Novartis AG; Merck and Co Inc.; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca Plc.; GlaxoSmithKline Plc; Takeda Pharmaceutical Company Limited; Boehringer Ingelheim GmbH; Wyeth Pharmaceuticals Inc.; AstraZeneca Pharmaceuticals LP; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Lupin Limited; Cadila Pharmaceuticals; Almirall S.A.; Akorn Operating Company LLC; Kudco Ireland Ltd; Prestige Consumer Healthcare Inc.; GMP Laboratories of America Inc.; The Betty Mills Company; Acura Pharmaceuticals Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cough Hypersensitivity Syndrome Market Characteristics

    3. Cough Hypersensitivity Syndrome Market Trends And Strategies

    4. Cough Hypersensitivity Syndrome Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Cough Hypersensitivity Syndrome Market Size and Growth

    5.1. Global Cough Hypersensitivity Syndrome Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cough Hypersensitivity Syndrome Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cough Hypersensitivity Syndrome Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cough Hypersensitivity Syndrome Market Segmentation

    6.1. Global Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Inhales Corticosteroids

    Antitussive Agents

    Short-acting Beta-2 Agonists

    Anticholinergics

    Proton Pump Inhibitors

    Antihistamines

    Other Drugs

    6.2. Global Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Inhalation

    Other Route Of Administration

    6.3. Global Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Specialty Clinics

    Homecare

    Other End-Users

    7. Cough Hypersensitivity Syndrome Market Regional And Country Analysis

    7.1. Global Cough Hypersensitivity Syndrome Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cough Hypersensitivity Syndrome Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cough Hypersensitivity Syndrome Market  

    8.1. Asia-Pacific Cough Hypersensitivity Syndrome Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cough Hypersensitivity Syndrome Market  

    9.1. China Cough Hypersensitivity Syndrome Market Overview  

    9.2. China Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cough Hypersensitivity Syndrome Market  

    10.1. India Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cough Hypersensitivity Syndrome Market  

    11.1. Japan Cough Hypersensitivity Syndrome Market Overview  

    11.2. Japan Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cough Hypersensitivity Syndrome Market  

    12.1. Australia Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cough Hypersensitivity Syndrome Market  

    13.1. Indonesia Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cough Hypersensitivity Syndrome Market  

    14.1. South Korea Cough Hypersensitivity Syndrome Market Overview  

    14.2. South Korea Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cough Hypersensitivity Syndrome Market  

    15.1. Western Europe Cough Hypersensitivity Syndrome Market Overview

    15.2. Western Europe Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cough Hypersensitivity Syndrome Market  

    16.1. UK Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cough Hypersensitivity Syndrome Market  

    17.1. Germany Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cough Hypersensitivity Syndrome Market  

    18.5. France Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cough Hypersensitivity Syndrome Market  

    19.9. Italy Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cough Hypersensitivity Syndrome Market  

    20.13. Spain Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cough Hypersensitivity Syndrome Market  

    21.1. Eastern Europe Cough Hypersensitivity Syndrome Market Overview

    21.2. Eastern Europe Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cough Hypersensitivity Syndrome Market  

    22.1. Russia Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cough Hypersensitivity Syndrome Market  

    23.1. North America Cough Hypersensitivity Syndrome Market Overview

    23.2. North America Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cough Hypersensitivity Syndrome Market  

    24.1. USA Cough Hypersensitivity Syndrome Market Overview

    24.2. USA Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cough Hypersensitivity Syndrome Market  

    25.1. Canada Cough Hypersensitivity Syndrome Market Overview

    25.2. Canada Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cough Hypersensitivity Syndrome Market  

    26.1. South America Cough Hypersensitivity Syndrome Market Overview

    26.2. South America Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cough Hypersensitivity Syndrome Market  

    27.1. Brazil Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cough Hypersensitivity Syndrome Market  

    28.1. Middle East Cough Hypersensitivity Syndrome Market Overview

    28.2. Middle East Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cough Hypersensitivity Syndrome Market  

    29.1. Africa Cough Hypersensitivity Syndrome Market Overview

    29.2. Africa Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cough Hypersensitivity Syndrome Market Competitive Landscape And Company Profiles

    30.1. Cough Hypersensitivity Syndrome Market Competitive Landscape

    30.2. Cough Hypersensitivity Syndrome Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson and Johnson Ltd.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmann-La Roche AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Bayer AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Novartis AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Cough Hypersensitivity Syndrome Market Other Major And Innovative Companies

    31.1. Merck and Co Inc.

    31.2. Sanofi S.A.

    31.3. Bristol-Myers Squibb Company

    31.4. AstraZeneca Plc.

    31.5. GlaxoSmithKline Plc

    31.6. Takeda Pharmaceutical Company Limited

    31.7. Boehringer Ingelheim GmbH

    31.8. Wyeth Pharmaceuticals Inc.

    31.9. AstraZeneca Pharmaceuticals LP

    31.10. Teva Pharmaceutical Industries Ltd.

    31.11. Mylan N.V.

    31.12. Lupin Limited

    31.13. Cadila Pharmaceuticals

    31.14. Almirall S.A.

    31.15. Akorn Operating Company LLC

    32. Global Cough Hypersensitivity Syndrome Market Competitive Benchmarking

    33. Global Cough Hypersensitivity Syndrome Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Cough Hypersensitivity Syndrome Market

    35. Cough Hypersensitivity Syndrome Market Future Outlook and Potential Analysis

    35.1 Cough Hypersensitivity Syndrome Market In 2028 - Countries Offering Most New Opportunities

    35.2 Cough Hypersensitivity Syndrome Market In 2028 - Segments Offering Most New Opportunities

    35.3 Cough Hypersensitivity Syndrome Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cough Hypersensitivity Syndrome Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Cough Hypersensitivity Syndrome Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Johnson and Johnson Ltd. Financial Performance
  • Table 76: F. Hoffmann-La Roche AG Financial Performance
  • Table 77: Bayer AG Financial Performance
  • Table 78: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cough Hypersensitivity Syndrome Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Cough Hypersensitivity Syndrome Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Johnson and Johnson Ltd. Financial Performance
  • Figure 76: F. Hoffmann-La Roche AG Financial Performance
  • Figure 77: Bayer AG Financial Performance
  • Figure 78: Novartis AG Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Cough And Cold Preparations Global Market Report 2024 – By Drug Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Other Drug Types), By Dosage Type (Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges, Other Dosage Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Chronic Cough Global Market Report 2024 – By Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes), By Route Of Administration (Oral, Inhalational, Injectable, Other Route of Administrations), By End-Users (Hospitals, Homecare, Specialty Centers, Other End Users), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Global Market Report 2024 – By Type (Diagnostic devices, Therapeutic devices, Monitoring devices), By Therapeutic Devices (Humidifiers, Nebulizers, Oxygen concentrators, Positive Airway Pressure (PAP) Devices, Ventilators, Other Therapeutic Devices), By Diagnostic Devices (Spirometer, Polysomnographs, Peak Flow Meters), By Monitoring Devices (Pulse oximeters, Capnographs, Gas analyzers), By Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Obstructive Sleep Apnea (OSA), Respiratory Distress Syndrome (RDS), Cystic Fibrosis, Pneumonia), By End User (Hospitals, Clinics, Homecare settings, Ambulatory service centers,) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Disposables Global Market Report 2024 – By Type (Masks, Tubes, Inhalers, Other Types), By Disease Indications (Asthma, Chronic Obstructive Pulmonary Disorder, Tuberculosis, Lung Cancer, Other Chronic Respiratory Diseases), By Application (Adult, Pediatric & Neonatal), By End User (Hospitals, Clinics, Ambulatory Care Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2024 – By Product (Instruments And Devices, Assays And Reagents), By Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests), By Disease Type (Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Diseases), By End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Devices And Equipment (Therapeutic) Global Market Report 2024 – By Product (Nebulizers, Humidifiers, Oxygen Concentrators, Positive Airway Pressure Devices, Ventilators, Capnographs, Gas Analyzers), By Technology (HEPA Filter, Electrostatic Filtration, Microsphere Separation, Hollow Fiber Filtration, Other Technologies), By End-User (Homecare settings, Hospitals) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Monitoring Devices Global Market Report 2024 – By Type (Capnographs, Gas Analyzers, Pulse Oximeters, Peak Flow Meters, Spirometers, Polysomnographs, Others Types), By Application (Chronic Obstructive Pulmonary Disease (COPD), Infectious Diseases, Asthma, Other Applications), By End-User (Laboratories, Hospitals, Home Use) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Anesthesia And Respiratory Devices Global Market Report 2024 – By Type (Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), By Gender (Male, Female), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the cough hypersensitivity syndrome market?

Cough hypersensitivity syndrome (CHS) is a medical condition characterized by an exaggerated and abnormal response of the cough reflex to various stimuli, often leading to persistent and chronic coughing. It is commonly associated with conditions such as asthma, gastroesophageal reflux disease (GERD) and upper airway disorders. request a sample here

How will the cough hypersensitivity syndrome market drivers and restraints affect the cough hypersensitivity syndrome market dynamics? What forces will shape the cough hypersensitivity syndrome industry going forward?

The cough hypersensitivity syndrome market major growth driver - Growing Prevalence Of Chronic Respiratory Diseases Boosts The Cough Hypersensitivity Syndrome Market. request a sample here

What is the forecast market size or the forecast market value of the cough hypersensitivity syndrome market?

The cough hypersensitivity syndrome market size has grown strongly in recent years. It will grow from $9.71 billion in 2023 to $10.36 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased awareness, telemedicine and remote monitoring, public health initiatives, research funding. The cough hypersensitivity syndrome market size is expected to see strong growth in the next few years. It will grow to $13.51 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to global health access, patient advocacy and support, quality of life improvements. Major trends in the forecast period include improved diagnosis and screening tools, personalized treatment approaches, new medications. request a sample here

How is the cough hypersensitivity syndrome market segmented?

The cough hypersensitivity syndrome market is segmented
1) By Drug Class: Inhales Corticosteroids, Antitussive Agents, Short-acting Beta-2 Agonists, Anticholinergics, Proton Pump Inhibitors, Antihistamines, Other Drugs
2) By Route of Administration: Oral, Inhalation, Other Route Of Administration
3) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-UsersFor further insights on the cough hypersensitivity syndrome market request a sample here

Which region has the largest share of the cough hypersensitivity syndrome market? What are the other regions covered in the report?

North America was the largest region in the cough hypersensitivity syndrome market in 2023. The regions covered in cough hypersensitivity syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the cough hypersensitivity syndrome market?

Major players in the cough hypersensitivity syndrome market are Pfizer Inc., Johnson and Johnson Ltd., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck and Co Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Wyeth Pharmaceuticals Inc., AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Mylan N.V., Lupin Limited, Cadila Pharmaceuticals, Almirall S.A., Akorn Operating Company LLC, Kudco Ireland Ltd., Prestige Consumer Healthcare Inc., GMP Laboratories of America Inc., The Betty Mills Company, Acura Pharmaceuticals Inc. request a sample here.

What are the key trends in the cough hypersensitivity syndrome market?

Major trend in the cough hypersensitivity syndrome market - Integration Of Ai-Powered Algorithms Drives Advancements In The Cough Hypersensitivity Syndrome Market. request a sample here.

What are the major opportunities in the cough hypersensitivity syndrome market? What are the strategies for the cough hypersensitivity syndrome market?

For detailed insights on the major opportunities and strategies in the cough hypersensitivity syndrome market, request a sample here.

How does the cough hypersensitivity syndrome market relate to the overall economy and other similar markets?

For detailed insights on cough hypersensitivity syndrome market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cough hypersensitivity syndrome industry?

For detailed insights on the mergers and acquisitions in the cough hypersensitivity syndrome industry, request a sample here.

What are the key dynamics influencing the cough hypersensitivity syndrome market growth? SWOT analysis of the cough hypersensitivity syndrome market.

For detailed insights on the key dynamics influencing the cough hypersensitivity syndrome market growth and SWOT analysis of the cough hypersensitivity syndrome industry, request a sample here.